v3.25.1
Liquidity, Going Concern, and Restatement - Schedule of Impact of the Restatement (Details) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Schedule of Impact of the Restatement [Line Items]        
Prepaid expense and other current asset $ 96,362 $ 383,309 $ 96,213  
Property and equipment, net   549,150    
Prepayment for asset acquisition 691,900 691,900 691,900  
Total Assets 14,875,699 7,976,010 7,539,907  
Accrued expenses and other current liabilities 3,826,819 3,445,667 3,509,422  
Convertible notes payable – third parties, net   872,336    
Current Liabilities 6,730,739 6,177,706 6,557,461  
Total Liabilities 6,919,404 6,517,539 6,815,948  
Additional paid-in capital   77,004,201    
Total stockholders’ equity 5,404,386 1,699,551 1,226,140  
Noncontrolling interest 2,551,909 (241,081) (502,181)  
Total Equity 7,956,295 1,458,470 723,959 $ 1,253,473
Total Liabilities and Equity 14,875,699 7,976,009 7,539,907  
Selling, general and administrative expenses 615,371 738,486    
Stock based compensation 48,773 2,031,631    
Interest expenses   (181,676)    
Net loss attributable to noncontrolling interests (102,115) (93,468)    
Net loss $ (944,190) $ (2,927,667)    
Basic and diluted net loss per common share (in Dollars per share) $ (0.06) $ (0.29)    
Diluted net loss per common share (in Dollars per share) $ (0.06) $ (0.29)    
Net loss $ 944,190 $ (2,927,664)    
Other non-cash income and expenses   176,280    
Accrued expenses and other current liabilities 40,113 (43,605)    
Due to related parties      
Net cash used in operating activities (539,833) (955,816)    
Due to related parties [1]   (217,981)    
Net cash provided by financing activities 428,756 924,147    
Effect of exchange rate changes on cash and cash equivalents and restricted cash   (26,109)    
Issuance of common stock for conversion of debt   467,574    
Related Party [Member]        
Schedule of Impact of the Restatement [Line Items]        
Due to related parties $ 819,384 391,474 $ 773,045  
As Reported [Member]        
Schedule of Impact of the Restatement [Line Items]        
Prepaid expense and other current asset   159,602    
Property and equipment, net   7,949,150    
Prepayment for asset acquisition      
Total Assets   14,460,402    
Accrued expenses and other current liabilities   4,050,845    
Convertible notes payable – third parties, net   842,567    
Current Liabilities   6,633,614    
Total Liabilities   6,973,447    
Additional paid-in capital   86,029,237    
Total stockholders’ equity   7,792,076    
Noncontrolling interest   (305,121)    
Total Equity   7,486,955    
Total Liabilities and Equity   14,460,402    
Selling, general and administrative expenses   831,257    
Stock based compensation   2,544,995    
Interest expenses   (684,683)    
Net loss attributable to noncontrolling interests   (48,043)    
Net loss   $ (3,981,019)    
Basic and diluted net loss per common share (in Dollars per share)   $ (0.4)    
Diluted net loss per common share (in Dollars per share)   $ (0.4)    
Net loss   $ (3,981,019)    
Other non-cash income and expenses   672,016    
Accrued expenses and other current liabilities   354,465    
Due to related parties   128,840    
Net cash used in operating activities   (602,001)    
Due to related parties [1]      
Net cash provided by financing activities   805,006    
Effect of exchange rate changes on cash and cash equivalents and restricted cash   (260,783)    
Issuance of common stock for conversion of debt   681,000    
As Reported [Member] | Related Party [Member]        
Schedule of Impact of the Restatement [Line Items]        
Due to related parties   301,972    
Adjustments [Member]        
Schedule of Impact of the Restatement [Line Items]        
Prepaid expense and other current asset   223,707    
Property and equipment, net   (7,400,000)    
Prepayment for asset acquisition   691,900    
Total Assets   (6,484,392)   $ 6,708,100
Accrued expenses and other current liabilities   (605,178)    
Convertible notes payable – third parties, net   29,769    
Current Liabilities   (455,908)    
Total Liabilities   (455,908)    
Additional paid-in capital   (9,025,036)    
Total stockholders’ equity   (6,092,525)    
Noncontrolling interest   64,040    
Total Equity   (6,028,485)    
Total Liabilities and Equity   (6,484,393)    
Selling, general and administrative expenses   (92,771)    
Stock based compensation   (513,364)    
Interest expenses   503,007    
Net loss attributable to noncontrolling interests   (45,425)    
Net loss   $ 1,053,352    
Basic and diluted net loss per common share (in Dollars per share)   $ 0.11    
Diluted net loss per common share (in Dollars per share)   $ 0.11    
Net loss   $ 1,053,355    
Other non-cash income and expenses   (495,736)    
Accrued expenses and other current liabilities   (398,070)    
Due to related parties   (128,840)    
Net cash used in operating activities   (353,815)    
Due to related parties [1]   (217,981)    
Net cash provided by financing activities   119,141    
Effect of exchange rate changes on cash and cash equivalents and restricted cash   234,674    
Issuance of common stock for conversion of debt   213,426    
Adjustments [Member] | Related Party [Member]        
Schedule of Impact of the Restatement [Line Items]        
Due to related parties   $ 89,502    
[1] Due to related parties previously reported amount was reclassified to financing activities based on current year’s presentation.